Document:

<PAGE>

                                                                 EXHIBIT 10.15

                                 AMENDMENT NO. 6
--------------------------------------------------------------------------------

                  Amendment No. 6 (this "Amendment"), dated as of February 11,
2000, among ALARIS MEDICAL, INC. a Delaware corporation ("Holdings"), ALARIS
MEDICAL SYSTEMS, INC., a Delaware corporation (the "Borrower"), the financial
institutions party to the Credit Agreement referred to below (the "Banks"),
BANKERS TRUST COMPANY, as Administrative Agent and as a Syndication Agent and
BANQUE PARIBAS, as Documentation Agent (together with Bankers Trust Company in
its capacity as Administrative Agent, the "Agents") and as a Syndication Agent.
All capitalized terms used herein and not otherwise defined shall have the
respective meanings provided such terms in the Credit Agreement referred to
below.

                              W I T N E S S E T H:

                  WHEREAS, Holdings, the Borrower, the Banks and the Agents are
parties to a Credit Agreement, dated as of November 26, 1996 (as modified,
supplemented and amended to, but not including, the date hereof, the "Credit
Agreement"); and

                  WHEREAS, the parties hereto wish to amend the Credit Agreement
as set forth herein;

                  NOW, THEREFORE, it is agreed:

                  1. The table appearing in Section 8.09 of the Credit Agreement
is hereby deleted in its entirety and the following new table is hereby inserted
in lieu thereof:

<TABLE>
<CAPTION>
                                                         MINIMUM CONSOLIDATED
                           "DATE                                EBITDA
                            ----                         --------------------
                    <S>                                  <C>
                     December 31, 1999                         $87,800,000

                      March 31, 2000                           $81,200,000
                       June 30, 2000                           $85,600,000
                    September 30, 2000                         $86,400,000
                     December 31, 2000                         $90,000,000

                      March 31, 2001                           $93,500,000
                       June 30, 2001                           $95,500,000
                    September 30, 2001                         $96,400,000
                     December 31, 2001                        $100,200,000

<PAGE>

                      March 31, 2002                           $109,500,000
                       June 30, 2002                           $111,900,000
                    September 30, 2002                         $114,300,000
                     December 31, 2002                         $117,200,000

                      March 31, 2003                           $118,600,000
                       June 30, 2003                           $120,300,000
                    September 30, 2003                         $122,100,000
                     December 31, 2003                         $124,200,000

                      March 31, 2004                           $125,700,000
                       June 30, 2004                           $127,500,000
                    September 30, 2004                         $129,400,000
                     December 31, 2004                         $131,600,000

                      March 31, 2005                           $132,600,000
                       June 30, 2005                           $133,900,000".
</TABLE>

                  2. The table appearing in Section 8.10 of the Credit Agreement
is hereby deleted in its entirety and the following new table is hereby inserted
in lieu thereof:

<TABLE>
<CAPTION>
                           "DATE                                RATIO
                            ----                                -----
                    <S>                                       <C>
                     December 31, 1999                        2.30:1.00

                      March 31, 2000                          2.10:1.00
                       June 30, 2000                          2.20:1.00
                    September 30, 2000                        2.25:1.00
                     December 31, 2000                        2.30:1.00

                      March 31, 2001                          2.40:1.00
                       June 30, 2001                          2.50:1.00
                    September 30, 2001                        2.60:1.00
                     December 31, 2001                        2.70:1.00

                      March 31, 2002                          3.00:1.00
                       June 30, 2002                          3.10:1.00
                    September 30, 2002                        3.25:1.00
                     December 31, 2002                        3.35:1.00

                      March 31, 2003                          3.50:1.00
                       June 30, 2003                          3.65:1.00
                    September 30, 2003                        3.70:1.00
                     December 31, 2003                        3.75:1:00

<PAGE>

                      March 31, 2004                          4.05:1.00
                       June 30, 2004                          4.15:1.00
                    September 30, 2004                        4.20:1.00
                     December 31, 2004                        4.25:1.00

                      March 31, 2005                          4.50:1.00
                       June 30, 2005                          4.75:1.00".
</TABLE>

                  3. The table appearing in Section 8.11 of the Credit Agreement
is hereby deleted in its entirety and the following new table is hereby inserted
in lieu thereof:

<TABLE>
<CAPTION>
                  "FISCAL QUARTER ENDING                     RATIO
                   ---------------------                     -----
                   <S>                                     <C>
                     December 31, 1999                     4.50:1.00

                      March 31, 2000                       4.80:1.00
                       June 30, 2000                       4.50:1.00
                    September 30, 2000                     4.40:1.00
                     December 31, 2000                     4.30:1.00

                      March 31, 2001                       4.10:1.00
                       June 30, 2001                       3.90:1.00
                    September 30, 2001                     3.80:1.00
                     December 31, 2001                     3.60:1.00

                      March 31, 2002                       3.20:1.00
                       June 30, 2002                       3.10:1.00
                    September 30, 2002                     2.95:1.00
                     December 31, 2002                     2.85:1.00

                      March 31, 2003                       2.75:1.00
                       June 30, 2003                       2.65:1.00
                    September 30, 2003                     2.55:1.00
                     December 31, 2003                     2.50:1.00

                      March 31, 2004                       2.40:1.00
                       June 30, 2004                       2.35:1.00
                    September 30, 2004                     2.30:1.00
                     December 31, 2004                     2.25:1.00

                      March 31, 2005                       2.05:1.00
                       June 30, 2005                       1.75:1.00".
</TABLE>

<PAGE>

                  4. Section 10 of the Credit Agreement is hereby amended by
deleting the definitions of "Applicable Base Rate Margin" and "Applicable
Eurodollar Margin" appearing therein in their entirety and inserting the
following new definitions of "Applicable Base Rate Margin" and "Applicable
Eurodollar Margin" in lieu thereof:

                  "Applicable Base Rate Margin" shall mean (i) in the case of A
         Term Loans and Revolving Loans, 1.75%, less the Applicable Performance
         Discount, if any, and (ii) in the case of B Term Loans, C Term Loans
         and D Term Loans, 2.25%.

                  "Applicable Eurodollar Margin" shall mean (i) in the case of A
         Term Loans and Revolving Loans, 3.00%, less the Applicable Performance
         Discount, if any, and (ii) in the case of B Term Loans, C Term Loans
         and D Term Loans, 3.50%.

                  5. Holdings, the Borrower and the Banks hereby agree that
retroactive effect shall be given to the modifications to the definitions of
"Applicable Base Rate Margin" and "Applicable Eurodollar Rate Margin" provided
for in Section 4 of this Amendment as if such modifications had occurred on
December 22, 1999.

                  6. In order to induce the Banks to enter into this Amendment,
each of Holdings and the Borrower hereby represents and warrants that (i) other
than the receipt by the Borrower of a Warning Letter attached hereto as Exhibit
A, the representations, warranties and agreements contained in the Credit
Agreement and the other Credit Documents are true and correct in all material
respects on and as of the Amendment Effective Date (as defined below), after
giving effect to this Amendment, and (ii) there exists no Default or Event of
Default on the Amendment Effective Date, after giving effect to this Amendment.

                  7. This Amendment is limited as specified and shall not
constitute a modification, acceptance or waiver of any other provision of the
Credit Agreement or any other Credit Document.

                  8. This Amendment may be executed in any number of
counterparts and by the different parties hereto on separate counterparts, each
of which counterparts when executed and delivered shall be an original, but all
of which shall together constitute one and the same instrument. A complete set
of counterparts shall be lodged with Holdings, the Borrower and the Agents.

                  9. THIS AMENDMENT AND THE RIGHTS AND OBLIGATIONS OF THE
PARTIES HEREUNDER SHALL BE CONSTRUED IN ACCORDANCE WITH AND GOVERNED BY THE LAW
OF THE STATE OF NEW YORK.

                  10. This Amendment shall become effective on the date (the
"Amendment Effective Date") when (i) each of Holdings, the Borrower, the Agents
and the Required Banks shall have signed a counterpart hereof (whether the same
or different

<PAGE>

counterparts) and shall have delivered (including by way of telecopier) the
same to the Administrative Agent at the Notice Office and (ii) thereafter the
Borrower shall have paid to the Administrative Agent for the account of each
Bank that has executed a counterpart hereof and delivered same to the
Administrative Agent at the Notice Office on or prior to 5:00 P.M. (New York
time) on February 11, 2000, an amendment fee equal to 0.25% of the sum of
such Bank's outstanding A Term Loans, B Term Loans, C Term Loans, D Term
Loans and Revolving Loan Commitments, in each case at such time.

                  11. From and after the Amendment Effective Date, all
references in the Credit Agreement and in the other Credit Documents to the
Credit Agreement shall be deemed to be references to the Credit Agreement as
modified hereby.

                                      * * *

                  IN WITNESS WHEREOF, each of the parties hereto has caused a
counterpart of this Amendment to be duly executed and delivered as of the date
first above written.

                         ALARIS MEDICAL, INC.

                         By:
                             ------------------------------
                             Name:
                             Title:

                         ALARIS MEDICAL SYSTEMS, INC.

                         By:
                             ------------------------------
                             Name:
                             Title:

                         BANKERS TRUST COMPANY,
                         Individually and as Administrative Agent

                         By:
                             ------------------------------
                             Name:
                             Title:

<PAGE>

                         PARIBAS,
                         Individually and as Documentation Agent

                         By:
                             ------------------------------
                             Name:
                             Title:

                         By:
                             ------------------------------
                             Name:
                             Title:

                         PARIBAS CAPITAL FUNDING

                         By:
                             ------------------------------
                             Name:
                             Title:

                         GENERAL ELECTRIC CAPITAL CORPORATION

                         By:
                             ------------------------------
                             Name:
                             Title:

                         UNION BANK OF CALIFORNIA, N.A.

                         By:
                             ------------------------------
                             Name:
                             Title:

                         U.S. BANK NATIONAL ASSOCIATION

                         By:
                             ------------------------------
                             Name:
                             Title:

                         IBJ WHITEHALL BANK & TRUST COMPANY

                         By:
                             ------------------------------
                             Name:
                             Title:

<PAGE>

                         MERRILL LYNCH SENIOR FLOATING RATE FUND, INC.

                         By:
                             ------------------------------
                             Name:
                             Title:

                         SENIOR HIGH INCOME PORTFOLIO, INC.

                         By:
                             ------------------------------
                             Name:
                             Title:

                         ML CBO IV (Cayman) Ltd.

                         By:    Highland Capital Management L.P.,
                                as Collateral Manager

                         By:
                             ------------------------------
                             Name:
                             Title:

                         JACKSON NATIONAL LIFE INSURANCE COMPANY

                         By:    PPM America, Inc., as attorney in fact,
                                on behalf of Jackson National Life
                                Insurance Company

                         By:
                             ------------------------------
                             Name:
                             Title:

<PAGE>

                         CRESCENT/MACH I PARTNERS, L.P.

                         By:      TCW Asset Management Company, its
                                  Investment Manager

                         By:
                             ------------------------------
                             Name:
                             Title:

                         METROPOLITAN LIFE INSURANCE COMPANY

                         By:
                             ------------------------------
                             Name:
                             Title:

                         OCTAGON INVESTMENT PARTNERS II

                         By:  Octagon Credit Investors, LLC, as
                              Subinvestment Manager

                         By:
                             ------------------------------
                             Name:
                             Title:

                         OCTOGAN LOAN TRUST

                         By:  Octagon Credit Investors, as Manager

                         By:
                             ------------------------------
                             Name:
                             Title:

                         INDOSUEZ CAPITAL FUNDING III, LIMITED

                         By:  Indosuez Capital, as Portfolio Advisor

                         By:
                             ------------------------------
                             Name:
                             Title:

<PAGE>

                         PRIME INCOME TRUST

                         By:
                             ------------------------------
                             Name:
                             Title:

                         SENIOR DEBT PORTFOLIO

                         By:  Boston Management and Research, as
                              Investment Advisor

                         By:
                             ------------------------------
                             Name:
                             Title:

                         COMMERCIAL LOAN FUNDING TRUST I

                         By:  Lehman Commercial Paper Inc., not in single
                              capacity but solely as Administrative Agent

                         By:
                             ------------------------------
                             Name:
                             Title:

                         PAMCO CAYMAN LTD.

                         By:  Highland Capital Management, L.P.,
                               as Collateral Manager

                         By:
                             ------------------------------
                             Name:
                             Title:

<PAGE>

                         PAM CAPITAL FUNDING L.P.

                         By:  Highland Capital Management, L.P.,
                              as Collateral Agent

                         By:
                             ------------------------------
                             Name:
                             Title:

                         KZH CRESCENT-3 LLC

                         By:
                             ------------------------------
                             Name:
                             Title:

                         SENIOR DEBT PORTFOLIO

                         By:  Boston Management and Research,
                               as Investment Advisor

                         By:
                             ------------------------------
                             Name:
                             Title:

                         EATON VANCE SENIOR INCOME TRUST

                         By:  Eaton Vance Management,
                               as Investment Advisor

                         By:
                             ------------------------------
                             Name:
                             Title:

                         OXFORD STRATEGIC INCOME FUND

                         By:  Eaton Vance Management,
                              as Investment Advisor

                         By:
                             ------------------------------
                             Name:
                             Title:

<PAGE>

                         TRANSAMERICA BUSINESS CREDIT CORPORATION

                         By:
                             ------------------------------
                             Name:
                             Title:

                         INDOSUEZ CAPITAL FUNDING IIA, LIMITED

                         By: Indosuez Capital as Portfolio Advisor

                         By:
                             ------------------------------
                             Name:
                             Title:

                         INDOSUEZ CAPITAL FUNDING IV, LP

                         By: Indosuez Capital as Portfolio Advisor

                         By:
                             ------------------------------
                             Name:
                             Title:

                         MERRILL LYNCH DEBT STRATEGIES FUND III, INC.

                         By:
                             ------------------------------
                             Name:
                             Title:

<PAGE>

                         UNITED OF OMAHA LIFE INSURANCE COMPANY

                         By:  TCW Asset Management Company, its
                                Investment Manager

                         By:
                             ------------------------------
                             Name:
                             Title:

                         SEQUILS I LTD

                         By:  TCW Asset Management Company, its
                                 Investment Manager

                         By:
                             ------------------------------
                             Name:
                             Title:<PAGE>

                                                                   EXHIBIT 10.16
October 29, 1999

ADDENDUM TO EMPLOYMENT LETTER DATED APRIL 13, 1999 BY AND BETWEEN DAVID
SCHLOTTERBECK AND ALARIS MEDICAL, INC., AND ALARIS MEDICAL SYSTEMS, INC.

         The Company is very pleased to inform you that you have been appointed
to the position of Chief Executive Officer and President effective November 1,
1999. Concurrently, you have been appointed as a member of the Company's Board
of Directors.

         Effective with your promotion to CEO, your compensation package will be
adjusted as follows: your base salary will be increased to $452,010 per year
(paid biweekly at a rate of $17,385); your target (and maximum potential) annual
bonus incentive will be 100% of your base (you will no longer be eligible to
participate in the Company's Financial Management Incentive Plan); you will be
granted 210,000 additional stock options 110,000 of which will be priced at the
fair market value (average of the high and low) of the Company's common stock on
the last trading day immediately proceeding the effective date of this promotion
and will vest quarterly over four years, and the balance of which, or 100,000,
will be Performance Options and will vest in the following cumulative
increments, 30%, 30%, and 40% when the closing price of the Company's common
stock equals or exceeds $7, $9 and $11 per share for at least 60 out of 66
consecutive trading days; you will be provided with a $1,000,000 life insurance
policy at a cost not to exceed $20,000/year, the beneficiary of which you may
designate; and, after three years from the effective date of this promotion,
should you desire to terminate this at-will employment relationship for any
reason, the Company agrees to provide you with separation pay in an amount equal
to twelve months' of your then existing base salary.

         This memorandum documents all of the changes to the terms of your
employment arrangement with the Company. Any additions or modifications of these
terms, or the terms left unchanged in your original employment letter, must be
in writing and signed by you and the Chairman of the Board of Directors.

         On Behalf of Company:                       Accepted:

         -----------------------------               ---------------------------
         Mr. Jeffry Picower                          Mr. David Schlotterbeck
         Chairman of the Board of Directors

<PAGE>

April 13, 1999

Mr. David Schlotterbeck
57 Poppy Hills Road
Laguna Niguel, California  92677

Dear Dave,

         We are pleased to offer you the position of President and Chief
Operating Officer with ALARIS Medical Systems, Inc. (subject to the Board of
Directors' approval of an amendment to the Corporate by-laws providing such
position), reporting to William J. Mercer, Chief Executive Officer. Should you
accept this offer, we would like you to start on/by April 19, 1999.

         Your initial pay rate will be $13,077 bi-weekly ($340,000 annualized)
and you will be eligible for the following relocation assistance as detailed on
the attached Relocation Agreement:

         -        Payment of actual reasonable costs to move your household
                  goods;

         -        A lump sum relocation allowance in the net amount of $28,334
                  (one month's salary) to cover any and all other relocation
                  expenses, including travel costs to actually move, and any and
                  all other miscellaneous relocation expenses and fees; and

         -        Net reimbursement for the actual Realtor commission on the
                  sale of your current residence (not to exceed 6% of the sale
                  price), and for the actual closing costs on the purchase of a
                  new residence (not to exceed 3% of the purchase price).

         You will also be eligible to participate in certain of the Company's
incentive bonus plans. Although bonus plans are dependent upon ALARIS Medical
Systems, Inc.'s financial results, and other Company and individual performance
criteria, your target bonus is 50% of your base salary earned for the calendar
year measured with a maximum bonus potential of 100% of your base salary. In
addition, you will be eligible for the Financial Management Incentive Plan,
which provides an additional bonus potential of $24,000 on an annual basis. For
1999, your bonuses, if any, will be prorated for the period employed in 1999. It
is also anticipated that your performance will be reviewed formally in the first
calendar quarter of the year 2000 and will be reviewed formally on an annual
basis thereafter.

         Also, you will be eligible to participate in the company's stock option
program. Under the terms of the option plan you will be granted 300,000 stock
options, subject to Board of Directors' approval. If granted, shares will be
priced at the fair market value (average high and low) of the Company's common
stock on the last trading day immediately preceding your date of hire, and will
be subject to four year quarterly vesting and other provisions stipulated in the
stock option agreement.

         As an executive officer of ALARIS Medical, you will be eligible to
participate in the "Amended and Restated Severance Plan." This provides for a
lump sum severance payment in an amount equal to twelve (12) months' base salary
in the event your employment is involuntarily terminated by ALARIS, subject to
the terms and conditions of that Plan (copy attached).

         As a regular full-time employee of ALARIS Medical Systems, you will be
eligible to participate in a number of Company-sponsored benefits. Through our
Flexible Benefits Program you are able to select

<PAGE>

the benefits that meet your individual needs. Benefits, which begin on your
hire date, include Medical/Dental (unless waived), Basic Group Life
Insurance, Long Term Disability Benefits, Vision Care, and Travel Accident
Insurance. Optional Benefits, in which you may elect to participate, include
supplemental life insurance for you and your spouse/dependents, all-cause
accidental death and dismemberment insurance for you and your
spouse/dependents, and 401(k) retirement program.

         All compensation and benefits will be administered in accordance with
ALARIS Medical Systems, Inc.'s policies and procedures, which may include
waiting periods and other eligibility requirements to participate. These
policies and procedures may change from time to time, without notice, during the
course of your employment. Chris Lemoine in Human Resources can answer your
benefits related questions. You can reach her by calling (619) 458-7880.

         Employment with ALARIS Medical is not for a specific term and may be
terminated with or without cause and with or without notice by you or by ALARIS
Medical at any time and for any reason. This offer letter supersedes any
contrary representations which may have been made or which may subsequently be
made to you. The at-will nature of your employment described in this offer
letter shall constitute the entire agreement between you and the Company
concerning the nature of your employment. Any additions or modifications of
these terms would have to be in writing and signed by you and the President of
the Company.

         Your employment pursuant to this offer is contingent upon:

         -        Successful completion of your pre-placement physical
                  examination and drug urine screen;

         -        Your providing the Company with the legally required proof of
                  your identity and authorization to work in the United States;

         -        Your signing and returning the attached "Application for
                  Employment;"

         -        Your signing and returning the attached "Relocation
                  Agreement;"

         -        Your execution of the "Confidentiality and Invention
                  Assignment Agreement" attached.

         In addition, it is very important that you comply with any
confidentiality obligations that you may have to your present or any former
employers.

         Dave, we sincerely hope that you accept this position. Please indicate
your acceptance of this offer by signing the enclosed copy and returning it to
me as soon as possible. This offer, if not accepted beforehand, will expire on
April 15, 1999. Please feel free to contact me at 619-458-7644 should you have
any questions. The Human Resources fax number is 619-458-6196. We look forward
to hearing from you soon.

                                   Sincerely,

                                   ALARIS Medical Systems, Inc.

                                   By:
                                      -----------------------------------
                                          L. James Runchey
                                          Vice President, Human Resources

         I HAVE READ, UNDERSTOOD, AND ACCEPT THE FOREGOING TERMS AND CONDITIONS
OF EMPLOYMENT. I FURTHER UNDERSTAND THAT WHILE MY COMPENSATION, BENEFITS, AND
JOB DUTIES MAY CHANGE FROM TIME TO TIME WITHOUT A WRITTEN MODIFICATION OF THIS
AGREEMENT, THE AT-WILL TERMS OF MY EMPLOYMENT IS A CONDITION OF EMPLOYMENT WHICH
CANNOT BE ALTERED OR MODIFIED EXCEPT IN WRITING SIGNED BY ME

<PAGE>

AND THE COMPANY PRESIDENT.

--------------------------------------      --------------------------
David Schlotterbeck                                     Date

cc: Bill Mercer
    Jerry Edge

<PAGE>

                              RELOCATION AGREEMENT

To accept the position of President and Chief Operating Officer in San Diego,
California with ALARIS Medical Systems, Inc., I understand and agree in order to
receive the relocation benefits outlined herein, that it is necessary for me to
relocate as a condition of accepting this position.

I further understand and agree that my employment with ALARIS Medical Systems,
Inc. is on an "at will" basis, meaning that either the company or I can
terminate the employment relationship at any time, for any reason or no reason,
with or without notice.

I desire to relocate from Laguna Niguel, California to the San Diego, California
area and am willing to do so on the terms set forth in this Relocation
Agreement. I acknowledge that no promises, commitments, or representations have
been made to me regarding the longevity of my employment or the future business
plans of ALARIS Medical Systems, Inc.

The only representations made to me by ALARIS Medical Systems, Inc. concerning
the position being offered to me if I relocate are in my offer letter and this
Relocation Agreement. I understand that no one at ALARIS Medical Systems, Inc.
is authorized to make any promises, commitments, or representations concerning
my employment, other than those set forth in this Relocation Agreement, except
in writing signed by a representative of the Human Resources Department.

I understand that ALARIS Medical Systems, Inc. will provide the following
relocation assistance.

-        ALARIS Medical Systems, Inc. will pay the actual reasonable costs to
         move your household goods from current residence to new residence
         (company will contract with the moving company and pay the bill
         directly).

-        ALARIS Medical Systems, Inc. will pay directly to you, on the date of
         relocation, a net check in the amount of $28,334 (one month's salary)
         to cover any and all other relocation expenses, including travel costs
         to actually move, and any and all other miscellaneous relocation
         expenses and fees. This net check will be "grossed up" to cover any
         mandatory federal and state tax withholdings and the "grossed up"
         amount will be reflected as ordinary income to you in the year in which
         it is paid.

-        For a period up to three years after the hire date, ALARIS Medical
         Systems, Inc. will provide reimbursement for the actual Realtor
         commission on the sale of your current residence (not to exceed 6% of
         the sale price), and for the actual closing costs on the purchase of a
         new residence (not to exceed 3% of the purchase price). These combined
         reimbursements will be paid upon submission of documentation that these
         expenses have been incurred. This net check will be "grossed up" to
         cover any mandatory federal and state tax withholdings and the "grossed
         up" amount will be reflected as ordinary income to you in the year in
         which it is paid.

In consideration for the Company providing me this relocation assistance, on
behalf of myself and my heirs, successors, and assigns, I hereby waive, release,
and relinquish any claims I may have, whether known or unknown, against ALARIS
Medical Systems, Inc. and its employees, agents, and representatives, pursuant
to California Labor Code section 970, or common law claims for implied contract,
fraud, intentional misrepresentation, or negligent misrepresentation, based upon
or arising from my relocation. In connection with this release, I expressly
waive the provisions of California Civil Code section 1542, as well as any other
statutes or common law principles of similar effect.

Further, I understand that if I voluntarily terminate before completing one year
of employment following my relocation, I will be responsible for reimbursing the
company

<PAGE>

for the full amount of this relocation assistance.

I understand that signing this Relocation Agreement below is a condition of
employment. I understand that if I am married, I must have my spouse sign below
where indicated.

BY SIGNING BELOW, I ACKNOWLEDGE THAT I HAVE READ THIS RELOCATION AGREEMENT
DOCUMENT CAREFULLY, UNDERSTAND IT FULLY, AND AGREE TO ITS TERMS FREELY AND
VOLUNTARILY.

David Schlotterbeck
------------------------------------
Print Name

------------------------------------         ---------------------------------
Signature                                    Date

SPOUSAL ACKNOWLEDGMENT AND CONSENT (if applicable):

By signing below, I acknowledge and consent to the foregoing Relocation
Agreement.

------------------------------------
Print Name of Spouse

------------------------------------         ---------------------------------
Signature of Spouse                          Date

cc:  Finance

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00003-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00003-of-00352.parquet"}]]